Ceftazidime hydrate (Fortaz; Fortum; GR20263; LY-139381; GR-20263), the hydrated form of Ceftazidime, is a 3rd generation, broad-spectrum β-lactam antibiotic/cephalosporin antibiotic useful for the treatment of a number of bacterial infections.

RPW-24 is a novel and potent stimulator of host immune defenses.

Avibactam (NXL-104; NXL104; Avycaz) is a covalent/reversible non-β-lactam β-lactamase inhibitor approved for use in combination with ceftazidime by the FDA on February 25, 2015 for treating bacterial infections, including those caused by multi-drug resistant gram-negative bacterial pathogens.

Cefotaxime Sodium is a novel and potent Cephalosporin antibiotic agent.

Lefamulin (formerly also known as BC-3781; Xenleta) is a semi-synthetic, oral pleuromutilin antibiotic approved to treat adults with community-acquired bacterial pneumonia.

Meptyldinocap (also known as 2,4-DNOPC) is a novel and potent powdery mildew (Erysiphe necator) fungicide which shows protectant and post-infective activities.

Cefotetan Sodium (ICI-156834; YM-09330), a semisynthetic cephamycin antibiotic, is a potent and second-generation cephalosporin antibiotic active against a wide range of both aerobic and anaerobic gram-positive and gram-negative bacteria.

Ozenoxacin (formerly known as GF-001001-00; M-5120; T-3912; trade names Ozanex; Ozewid; Xepi) is a novel nonfluorinated topical quinolone class of antibiotic.

Tosufloxacin tosylate hydrate, formerly known as T-3262 and A-61827, is a potent fluoroquinolone antibiotic used to treat susceptible infections.

Ceftazidime (GR-20263; GR20263; LY-139381; Tazidime; Fortaz, Tazicef; Avycaz) is a potent, third generation, and broad-spectrum β-lactam antibiotic approved for use as an antimicrobial agent for treating febrile neutropenia in patients with cancer.